NCT02895061
- Conditions
- Alfacalcidol, Secondary Hyperparathyroidism, Hemodialysis, Endocrine System Diseases, Hyperparathyroidism, +2 more
- Locations
-
Not specified
Clinical trial condition
Alfacalcidol, Secondary Hyperparathyroidism, Hemodialysis
Explore clinical trials studying Alfacalcidol, Secondary Hyperparathyroidism, Hemodialysis. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies